Characteristic | Development cohort | Validation cohort | Interval validation cohort | |||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Patients(n, %) | 19,773 | 100.00 | 4944 | 100.00 | 6180 | 100.00 |
Age(years, mean ± SD) | 67.42 ± 20.19 | 67.58 ± 19.94 | 67.36 ± 20.02 | |||
Gender(male, %) | 9156 | 46.31 | 2318 | 46.89 | 2879 | 46.59 |
Income(n, %), medical aid | 465 | 2.35 | 104 | 2.10 | 155 | 2.51 |
1 | 2054 | 10.39 | 543 | 10.98 | 638 | 10.32 |
2 | 2349 | 11.88 | 590 | 11.93 | 729 | 11.80 |
3 | 3748 | 18.96 | 942 | 19.05 | 1200 | 19.42 |
4 | 4398 | 22.24 | 1077 | 21.78 | 1389 | 22.48 |
5 | 6635 | 33.56 | 1668 | 33.74 | 2042 | 33.04 |
Death(n, %) | 3731 | 18.87 | 919 | 18.59 | 1142 | 18.48 |
Rule-based method*(n, %) | 18,065 | 91.36 | 4534 | 91.71 | 5663 | 91.63 |
Ischemic stroke (n, %) | 1996 | 10.09 | 513 | 10.38 | 636 | 10.29 |